Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial

Background: The number of people with dementia is increasing, with huge challenges for society and health-care systems. There are no disease-modifying therapies available. There is, therefore, an urgent need to identify strategies to reduce the risk of developing dementia. Anthocyanins are a class o...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalifa, Khadija, Bergland, Anne Katrine, Soennesyn, Hogne, Oppedal, Ketil, Oesterhus, Ragnhild, Dalen, Ingvild, Larsen, Alf Inge, Fladby, Tormod, Brooker, Helen, Wesnes, Keith A., Ballard, Clive, Aarsland, Dag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492209/
https://www.ncbi.nlm.nih.gov/pubmed/32982933
http://dx.doi.org/10.3389/fneur.2020.00916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492209/
https://www.ncbi.nlm.nih.gov/pubmed/32982933
http://dx.doi.org/10.3389/fneur.2020.00916

Ejemplares similares